Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi Center Clinical Study of Chinese Medicine Intervention on Early Diabetic Microvascular Complications: Multi Centers Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

NCT03025399 is registered in ClinicalTrials.gov with Fengmei Lian as lead sponsor.

NCT NCT03025399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi Center Clinical Study of Chinese Medicine Intervention on Early Diabetic Microvascular Complications: Multi Centers Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy
Lead sponsor
Fengmei Lian
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2017
Completion date
May 31, 2020
Enrollment
384 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic non-proliferative retinopathy, type2 diabetes